Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5701459 | Journal of Thoracic Oncology | 2017 | 16 Pages |
Abstract
The abundance of EGFR activating mutation by ARMS+ was significantly associated with objective response to EGFR TKIs. The abundance of EGFRT790M mutation may have an adverse impact on progression-free survival rather than on objective response rate in patients with advanced EGFR-mutant NSCLC treated with EGFR TKIs.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Xuefei PhD, Weijing PhD, Guohua PhD, Chunxia PhD, Shengxiang PhD, Chao MD, Rongjun MD, Xiaoxia PhD, Guanghui Gao, Zhiwei PhD, Wei MD, Caicun MD, PhD, Fred R. MD, PhD,